Relive the conference
Read and watch our post-conference materials, you will be delighted by the spirit of pioneer and optimism it witnesses.
Be encouraged to join the movement towards new horizons in CMT research, based upon cooperation and partnership of scientists and clinicians both, with patients and industry.
Relive the conference via our YouTube-playlist with recorded sessions
Summary of the conference (in German)
via CMT-Austria
Backstage interviews with key opinion leaders
- Guests: Nathalie Bernard-Marissal & Kleopas Kleopa
- Topic: How basic scientists and clinicians can bridge the gap to create projects that move faster toward trials.
- Guests: Maike Dohrn & Evan Bailey
- Topic: A candid look at the economics of rare disease drugs and how industry views the CMT market.
- Guests: Lara Cantarero & Mary Reilly
- Topic: Whether finding more genes is still the priority, or if we should focus on treating the ones we already know.
- Guests: Filippo Genovese & René Westhovens
- Topic: The regulatory and reimbursement challenges that exist after a drug is proven to work scientifically.
- Guests: Connor Maltby & Alexander Leysen
- Topic: How patient organizations prepare their communities to fill clinical trials quickly and effectively.
- Guests: M. Drummond, M. Van Brussel & G. Fernandez
- Topic: The next generation of scientists discuss why they chose the CMT field and what excites them most.